Reaction
Subretinal Fibrosis reporting signals
As of the last recalculation, Subretinal Fibrosis appears in 193 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 566.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 81 | 566.3 | 568.1 |
| Faricimab | 13 | 185.4 | 185.7 |
| Aflibercept | 13 | 48.1 | 48.1 |